Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
FAPα-Responsive Nanoparticles for Urinary Tumor Diagnosis
2026-09-10
Feng and colleagues developed magnetic iron oxide nanoparticles carrying a substrate–reporter peptide that is cleaved by fibroblast activation protein α in tumor tissue, releasing a detectable urinary signal. In an esophageal squamous cell carcinoma xenograft model, the platform combined tumor biodistribution imaging with urine ELISA and achieved an area under the ROC curve of 1.0, while remaining a preclinical diagnostic strategy rather than a validated clinical test.
-
Baicalein Workflows for Cancer and Inflammation
2026-09-09
Build reproducible Baicalein assays around 12-LOX inhibition, apoptosis, inflammatory signaling, and cancer-cell phenotypes. This practical workflow also shows how to borrow assay logic from chemotherapy-neurotoxicity research without confusing evidence for formononetin with evidence for Baicalein.
-
A-769662: AMPK Activator Workflow
2026-09-09
A-769662 is a reversible AMPK activator for dissecting energy metabolism, lipid synthesis, autophagy signaling, and proteasome-linked cell-cycle phenotypes. This workflow emphasizes orthogonal readouts so researchers can separate genuine AMPK effects from the compound’s AMPK-independent proteasome activity.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-08
Cy3 Goat Anti-Mouse IgG (H+L) Antibody is a fluorescent mouse IgG detection antibody for visualizing mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. It is intended for research use only; assay-specific dilution, background, sensitivity, and live-cell compatibility should be established experimentally rather than assumed.
-
Plant Cell Lysis Buffer for WB and IP Workflow
2026-09-08
Build cleaner Western blots, native immunoprecipitations, and co-IP assays from challenging plant samples with a non-denaturing detergent-and-inhibitor formulation. This workflow also explains how plant-focused extraction principles can inform mechanistic protein studies without overstating cross-species evidence.
-
NSC-23766 Rac GTPase Inhibitor Workflow
2026-09-07
NSC-23766 enables controlled interrogation of Rac1-dependent cytoskeletal remodeling, barrier integrity, apoptosis, and cancer-cell growth. This guide connects dose-response design with live-cell phagocytosis assays, helping researchers distinguish Rac1-specific effects from broader toxicity or pathway compensation.
-
BIBR 1532: Telomerase Inhibition Workflows
2026-09-07
BIBR 1532 enables mechanism-focused studies that separate immediate hTERT inhibition from later telomere attrition and apoptosis. This workflow guide combines telomerase activity assays, leukemia pathway profiling, and carefully controlled comparisons with DNA-damaging telomere strategies.
-
TRAP-1 Reactivates p53Y220C Through Induced Proximity
2026-09-05
The preprint reports TRAP-1, a mutant-specific chemical inducer of proximity that brings p53Y220C into a functional complex with BRD4 and restores transcriptional activity. In pancreatic cancer cell models, this mechanism rapidly induced p21 and other p53 target genes while suppressing growth, with ternary-complex-defective controls failing to reproduce the response.
-
ERCC1 Deficiency, p53, and Cisplatin Sensitivity
2026-09-04
Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that ERCC1 loss does not produce a uniform platinum response: cisplatin hypersensitivity depends strongly on retained wild-type p53. The study identifies DNA-PKcs and BRCA1-associated repair as potential tolerance mechanisms, refining interpretation of ERCC1 as a biomarker for platinum chemotherapy.
-
TCF25 Links Glucose Starvation to Lysosomal Cell Death
2026-09-04
Ren et al. identify TCF25 as a nutrient-responsive regulator that connects glucose starvation to V-ATPase-dependent lysosomal acidification, autophagy, and eventual lysosome-dependent cell death. The study provides a mechanistic framework for separating early metabolic adaptation from prolonged starvation injury and suggests experimental strategies for studying lysosomal iron handling in ischemic and metabolic disease.
-
Concanamycin A Workflow for V-ATPase Studies
2026-09-03
Build a controlled V-ATPase perturbation workflow around Concanamycin A to connect endosomal pH, trafficking, apoptosis, and invasion phenotypes. This guide combines product-specific dosing benchmarks with a practical framework for separating direct acidification effects from downstream sphingolipid and stress responses.
-
Acridine Orange hydrochloride: Practical Guide
2026-09-03
Acridine Orange hydrochloride provides cell-permeable fluorescent nucleic acid staining with green and red signal behavior that can support DNA and RNA differential staining, cell cycle analysis, and flow-based cytochemical workflows. It should be used as a nucleic-acid dye with assay-specific validation, not as a standalone apoptosis or organelle-function readout, and prepared solutions should not be stored long term.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-02
Yin et al. identify a brain-to-spinal μ-opioid receptor circuit that links lateral parabrachial, hypothalamic, and spinal neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical from thermal opioid effects and provides a circuit framework for testing receptor-specific contributions in neuropharmacology and pain mechanism research.
-
Azithromycin: From Stock Solution to Assay Signal
2026-09-02
Azithromycin is a macrolide antibiotic whose experimental value depends on more than ribosome targeting. This guide connects chemical-stability control, impurity-aware analytics, resistance interpretation, and cross-model assay design.
-
Baicalein: Designing Mechanism-Resolved Assays
2026-09-01
Baicalein is a 12-LOX-focused flavonoid for studying cancer cell proliferation inhibition, apoptosis, and inflammatory signaling. This guide uses a recent chemotherapy-neurotoxicity study to show how mechanism-specific controls and paired models can produce more informative Baicalein data.